Heights Capital Management, Inc Coll Plant Biotechnologies LTD Transaction History
Heights Capital Management, Inc
- $365 Billion
- Q3 2025
A detailed history of Heights Capital Management, Inc transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, Heights Capital Management, Inc holds 19,258 shares of CLGN stock, worth $38,323. This represents 0.01% of its overall portfolio holdings.
Number of Shares
19,258
Previous 275,082
93.0%
Holding current value
$38,323
Previous $377 Million
86.25%
% of portfolio
0.01%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding CLGN
# of Institutions
22Shares Held
2.29MCall Options Held
0Put Options Held
0-
Villere St Denis J & CO LLC589KShares$1.17 Million0.16% of portfolio
-
Pinnacle Associates LTD507KShares$1.01 Million0.02% of portfolio
-
Investment Management Of Virginia LLC464KShares$923,1590.63% of portfolio
-
Roumell Asset Management, LLC Chevy Chase, MD276KShares$550,0952.69% of portfolio
-
Amh Equity LTD200KShares$398,0000.73% of portfolio
About CollPlant Biotechnologies Ltd
- Ticker CLGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,086,500
- Market Cap $22.1M
- Description
- CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...